Women’s preferences for selective estrogen reuptake modulators: an investigation using the time trade-off technique

SpringerPlus

Table 1 Demographic and clinical characteristics of participants at moderate risk of breast cancer, high risk of breast cancer and those with a mutation in the BRCA1 or BRCA2 gene

Variable	Moderate risk		High risk		Mutation positive		Combined
	n=10		*n=56*		n=41		N=107
	M	SD	M	SD	M	SD	M	SD
Age (years)	41.8	10.2	44.5	11.0	41.2	10.7	43.0	10.8
	n	%	n	%	n	%	n	%
Ethnicity
Australian	4	40	45	80	30	73	79	74
European	3	30	6	11	4	10	13	12
Asian	0	0	2	4	2	5	4	4
Other	3	30	3	5	5	12	11	10
Relationship status
Single	1	10	16	29	14	34	32	30
Married/de facto	9	90	40	71	27	66	76	71
Children
Yes	5	50	11	20	16	39	32	30
No	5	50	45	80	25	61	75	70
Daughter/s
Yes	4	40	36	64	21	51	61	57
No	6	60	19	34	20	49	45	42
Want future children
Yes	4	40	10	18	8	20	22	21
No	4	40	40	71	28	68	72	67
Unsure	1	10	6	11	5	12	12	11
Menopausal status
Premenopausal	7	70	31	55	19	46	57	53
Perimenopausal	1	10	6	11	0	0	7	7
Menopausal	1	10	15	27	20	49	36	34
Unsure	1	10	4	7	2	5	7	7
Family history of prophylactic mastectomy
Yes	3	30	14	25	17	41	34	32
No	7	70	42	75	24	59	73	68
Family history of prophylactic oophorectomy
Yes	1	10	10	18	19	46	30	28
No	9	90	46	82	22	54	77	72
Family history of SERMs
Yes	5	56	26	46	10	24	41	38
No	4	44	30	54	30	73	64	60
Personal history of oophorectomy
Yes	0	0	8	14	19	46	27	25
No	10	100	48	86	22	54	80	75
Personal history of SERMs
Yes	1	10	12	21	5	12	18	17
No	9	90	44	79	36	88	89	83
Cigarettes per day
None	8	80	53	95	40	98	101	94
10 or less	2	20	3	5	0	0	5	5
11 to 20	0	0	0	0	1	2	1	1
History of blood clots
Yes	1	10	0	0	0	0	1	1
No	9	90	56	100	41	100	106	99